We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $245M
1-Year Est. Return 23.8%
This Fund
S&P 500
This Quarter Est. Return
+10.43%
1 Year Est. Return
+23.8%
3 Year Est. Return
+70.62%
5 Year Est. Return
+83.19%
10 Year Est. Return
+679.91%
AUM
$135M
AUM Growth
+$3.4M
Cap. Flow
-$8.47M
Cap. Flow %
-6.28%
Top 10 Hldgs %
36.94%
Holding
594
New
77
Increased
123
Reduced
117
Closed
103

Top Buys

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$445K
2
BND icon
Vanguard Total Bond Market
BND
+$441K
3
BIV icon
Vanguard Intermediate-Term Bond ETF
BIV
+$275K
4
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$270K
5
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$268K

Top Sells

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$288K
2
GWW icon
W.W. Grainger
GWW
+$259K
3
CRBG icon
Corebridge Financial
CRBG
+$240K
4
NTNX icon
Nutanix
NTNX
+$237K
5
CNM icon
Core & Main
CNM
+$235K

Sector Composition

Rank Sector Weight
1 Technology 7.03%
2 Healthcare 3%
3 Consumer Discretionary 2.99%
4 Industrials 2.87%
5 Financials 2.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOUR icon
451
Shift4
FOUR
$3.24B
$446 ﹤0.01%
6
-634
-99% -$37.8K
FHN icon
452
First Horizon
FHN
$12B
$439 ﹤0.01%
+31
New +$373
FBK icon
453
FB Financial Corp
FBK
$3.07B
$438 ﹤0.01%
+11
New +$364
GOGL
454
DELISTED
Golden Ocean Group
GOGL
$420 ﹤0.01%
+43
New +$358
CAMT icon
455
Camtek
CAMT
$7.67B
$416 ﹤0.01%
6
-2,840
-100% -$173K
CERS icon
456
Cerus
CERS
$516M
$415 ﹤0.01%
192
-531
-73% -$875
BEAM icon
457
Beam Therapeutics
BEAM
$2.77B
$408 ﹤0.01%
15
-51
-77% -$1.27K
DNA icon
458
Ginkgo Bioworks
DNA
$506M
$395 ﹤0.01%
6
-19
-76% -$1.16K
SRPT icon
459
Sarepta Therapeutics
SRPT
$1.92B
$386 ﹤0.01%
4
-1,549
-100% -$149K
FTRE icon
460
Fortrea Holdings
FTRE
$1.86B
$384 ﹤0.01%
11
– –
NTLA icon
461
Intellia Therapeutics
NTLA
$1.68B
$366 ﹤0.01%
12
-39
-76% -$1.12K
TRIN icon
462
Trinity Capital Inc.
TRIN
$1.72B
$363 ﹤0.01%
25
-9,022
-100% -$130K
AZZ icon
463
AZZ Inc
AZZ
$4.6B
$349 ﹤0.01%
+6
New +$295
MTLS
464
Materialise
MTLS
$398M
$348 ﹤0.01%
53
-203
-79% -$1.2K
NYT icon
465
New York Times
NYT
$10.3B
$343 ﹤0.01%
7
-3,245
-100% -$143K
CORT icon
466
Corcept Therapeutics
CORT
$12.1B
$325 ﹤0.01%
10
-4,596
-100% -$126K
SE icon
467
Sea Limited
SE
$80.5B
$324 ﹤0.01%
8
– –
TITN icon
468
Titan Machinery
TITN
$438M
$318 ﹤0.01%
11
-4,817
-100% -$125K
HPK icon
469
HighPeak Energy
HPK
$1.04B
$313 ﹤0.01%
+22
New +$349
BL icon
470
BlackLine
BL
$1.63B
$312 ﹤0.01%
+5
New +$283
NWE icon
471
NorthWestern Energy
NWE
$4.35B
$305 ﹤0.01%
6
-2,620
-100% -$131K
MAIN icon
472
Main Street Capital
MAIN
$5.52B
$303 ﹤0.01%
7
-4,208
-100% -$172K
FWRG icon
473
First Watch Restaurant Group
FWRG
$727M
$301 ﹤0.01%
15
-6,846
-100% -$123K
IPAR icon
474
Interparfums
IPAR
$3.84B
$288 ﹤0.01%
2
-965
-100% -$126K
LADR
475
Ladder Capital
LADR
$1.26B
$288 ﹤0.01%
25
-12,465
-100% -$133K
17 18
19
20 21

Similar funds

LHCM
Lloyd Harbor Capital Management Cold Spring Harbor, New York $245M AUM 141.83% 1-Year Est. Return
JP
JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return
LC
Longitude (Cayman) Grand Cayman, Cayman Islands $244M AUM
BNMT
Bawa N Mallick Trust Forest Hills, New York $244M AUM 19.8% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return

C.M. Bidwell & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, C.M. Bidwell & Associates held 594 positions worth $135M, up 2.6% from $131M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

C.M. Bidwell & Associates withdrew a net $8.47M in Q4 2023, closing 103 positions and reducing 117 holdings. Its most notable exit was Monster Beverage, an estimated $288K position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, C.M. Bidwell & Associates opened a new position in EOG Resources worth $234K.

  • C.M. Bidwell & Associates's largest Q4 2023 buy was EOG Resources: 1,938 shares worth $234K.
  • C.M. Bidwell & Associates added most to Vanguard Short-Term Bond ETF in Q4 2023, an estimated $445K increase.
  • C.M. Bidwell & Associates's biggest Q4 2023 reduction was W.W. Grainger, cutting an estimated $259K.
  • C.M. Bidwell & Associates fully exited Monster Beverage in Q4 2023, selling an estimated $288K.
  • C.M. Bidwell & Associates's ten largest holdings make up 37% of its $135M portfolio in Q4 2023.
  • C.M. Bidwell & Associates opened 77 new positions and closed 103 in Q4 2023.
  • C.M. Bidwell & Associates's portfolio value rose 2.6% quarter-over-quarter to $135M.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2023, filed 14 Feb 2024.